Navigation Links
Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR
Date:8/1/2014

Wellesley, Mass. (PRWEB) August 01, 2014

BCC Research (http://www.bccresearch.com) reveals in its new report, RNAi DRUG DELIVERY: TECHNOLOGIES AND GLOBAL MARKETS, that the global market RNA interference (RNAi) drug delivery technologies is expected to grow to nearly $38.8 billion by 2018, with a five-year compound annual growth rate (CAGR) of 27.2%. The aptamer delivery category, the fastest moving segment of the market, is moving at a phenomenal 58.2% CAGR.

The field of RNAi therapeutics has shown tremendous growth and has moved toward clinical trials. Nonetheless, the development of RNAi therapeutics is dependent on safe, effective, and clinically suitable delivery carriers. The nanoparticle delivery category is the largest segment of the overall market and is expected to grow to $33.4 billion by 2018, registering a CAGR of 25%.

However, the aptamer delivery category, which was valued at just $218 million in 2013, is expected to jump to nearly $2.2 billion in 2018. Aptamers offer several advantages compared to protein or small-molecule drugs, most notably their ease of production, low risk of inducing an immune reaction in humans, and amenability to chemical modifications that enhance their drug-like properties, including improved stability and residence time in the bloodstream.

“There has been immense progress in the field of nanotechnology for drug delivery, and efforts have been dedicated to the development of nanoparticle-based RNAi delivery systems,” says BCC Research biotechnology analyst Usha Nagavarapu. “A carefully engineered, multifunctional nanocarrier with targeting capabilities is needed to address the delivery challenges.”

The RNAi technologies market has application in the areas of therapeutics, research, and development (functional genomics; metabolism), drug discovery, and agriculture. The therapeutics application market is focused on oncology, neurology, cardiology, ophthalmology, and metabolic disorders, and is expected to grow in the next few years.

RNAi DRUG DELIVERY: TECHNOLOGIES AND GLOBAL MARKETS provides an overview of the global market for RNAi drug delivery technologies. It includes analyses of global market trends, with data from 2010, 2012, and 2013, estimates for 2018, projections of CAGRs through 2018, and profiles of companies important in the industry.

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven(dot)cumming(at)bccresearch(dot)com.

About BCC Research:

BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years, we have helped customers identify new market opportunities with accurate and reliable data and insight, including market sizing, forecasting, industry overviews, and identification of significant trends and key competitors. We partner with analysts who are experts in specific areas of industry and technology, providing unbiased measurements and assessments of global markets. Our clients include the top companies in industries around the world, as well as universities, business schools, start-ups, consulting firms, and investment companies. BCC Research is a unit of Eli Research LLC. Visit our website at http://www.bccresearch.com. Contact us: (+1) 781-489-7301 (U.S. Eastern Time), or email information(at)bccresearch(dot)com.

Note:
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49-2 Walnut Park, Wellesley, MA 02481, Telephone: (+1) 781-489-7301; Email: editor(at)bccresearch(dot)com as the source and publisher. Thank you.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12065711.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com
2. Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research
3. Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research
4. Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina
5. Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020
6. ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment
7. Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth
8. Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research
9. Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
10. Global Synthetic Biology Market 2014-2018
11. Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2019)... (PRWEB) , ... August 29, 2019 , ... ... year to teach in the Sustainable Medicines in Africa program, which includes a ... take place in Arusha, Tanzania September 2nd through 13th, 2019. Topics to ...
(Date:8/23/2019)... Wis. (PRWEB) , ... August 22, 2019 , ... The ... some of the most harmful germs and pathogens on hard surfaces including E. Coli, ... leaves behind no chemical residues. For more information, visit the product page at rovingblue.com ...
(Date:8/14/2019)... ... August 13, 2019 , ... Chata ... phases for QC laboratories. After gaining a few significant clients, Lifecycle purchased the ... a valued supplier of manufacturing processing solutions, including reagents for tissue processing. Chata ...
(Date:8/6/2019)... FARMINGTON, Conn. (PRWEB) , ... August 06, 2019 ... ... that develops tools for characterizing microbiome populations down to the strain level, has ... Biome’s microbiome kits and other products to companies and research organizations in Australia, ...
Breaking Biology Technology:
(Date:8/23/2019)... ... , ... R121 solidifies its place within The Planet Group ... with the name change, this rebranding includes a comprehensive redesign of the company’s ... brand that blended our core foundation of genuine ‘one-to-one’ relationships with Planet’s global ...
(Date:8/19/2019)... N.J. (PRWEB) , ... August 19, 2019 , ... ... have characterized tissues through the use of ultra-thin two dimensional slices which are ... can be highly limited for complex tissues and complicated features such as vasculature ...
(Date:8/14/2019)... ... August 14, 2019 , ... An upcoming episode ... in microbiome therapeutics are helping to promote normal immune function in order to ... will educate about the DECODE.DESIGN.CURE™ technology platform, which rapidly develops microbiome therapeutics in ...
Breaking Biology News(10 mins):